ELISA AND RAPID IMMUNO ASSAY KITS. PIPETTES. ישראל - עברית - Ministry of Health

elisa and rapid immuno assay kits. pipettes.

גאמידור דיאגנוסטיקה בע"מ - צוות טכני - elisa kits for in vitro use

אימיוסיסט ישראל - עברית - Ministry of Health

אימיוסיסט

medici ltd - bcg 81 mg/vial - powder for reconstitution - bcg vaccine - for the treatment of superficial transitional cell carcinoma (tcc) of the urinary bladder, regardless of antecedent intravesical treatment superficial tcc comprises the following: carcinoma in situ (cis), papillary tumors limited to the mucosa (stage ta), papillary tumors invoiving the lamina propria but not the muscle layer of the bladder (stage t1), or any combination thereof. immucyst is indicated for treatment and prophylaxis of primary or recurrent carcinoma insitu (cis) of the urinary bladder and for prophylaxis following trans-urethral resection (tur) of primary or recurrent stage ta and/or t1 papilary tumors.

זיפאדהרה 210 מ"ג ישראל - עברית - Ministry of Health

זיפאדהרה 210 מ"ג

eli lilly israel ltd - olanzapine 210 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

זיפאדהרה 300 מ"ג ישראל - עברית - Ministry of Health

זיפאדהרה 300 מ"ג

eli lilly israel ltd - olanzapine 300 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

זיפאדהרה 405 מ"ג ישראל - עברית - Ministry of Health

זיפאדהרה 405 מ"ג

eli lilly israel ltd - olanzapine as pamoate monohydrate 405 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

פונגימון ישראל - עברית - Ministry of Health

פונגימון

trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".

"ELISA Kits, RIA Kits, Blots, IFA Kits and Rapid tests kits" ישראל - עברית - Ministry of Health

"elisa kits, ria kits, blots, ifa kits and rapid tests kits"

"דיאסורין בע""מ" - אחר - "בתחומי אימונולוגינה, מיקרוביולוגיה ואנדוקרינולוגיה in vitro ביצוע בדיקות אבחוניות "

"ELISA Kits, RIA Kits, Blots, IFA Kits and Rapid tests kits" ישראל - עברית - Ministry of Health

"elisa kits, ria kits, blots, ifa kits and rapid tests kits"

"דיאסורין בע""מ" - אחר - "בתחומי אימונולוגינה, מיקרוביולוגיה ואנדוקרינולוגיה in vitro ביצוע בדיקות אבחוניות "

elisa analyzer-alegria ישראל - עברית - Ministry of Health

elisa analyzer-alegria

pharmatrade ltd. - מומחה - אנלייזר לבדיקות אלייזה

ELISA Kits, RIA Kits, Blots, IFA Kits and Rapid tests kits ישראל - עברית - Ministry of Health

elisa kits, ria kits, blots, ifa kits and rapid tests kits

דיאסורין בע"מ - אחר - בתחומי אימונולוגינה, מיקרוביולוגיה ואנדוקרינולוגיה in vitro ביצוע בדיקות אבחוניות